PAA 0.00% 19.5¢ pharmaust limited

Ann: Phase II Dog Lymphoma Trial Confirms MPL Clinical Benefit, page-24

  1. 16,819 Posts.
    lightbulb Created with Sketch. 356
    I know the slow and steady decline/accumulation phase in this stock has been hard for people to accept but it's going to pay off very strongly in the longer term because the company is now poised on many fronts to release steady and reliable news
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.